Finerenone Consistently Reduced Cardiorenal Risk Regardless of ASCVD History in FIDELITY
In patients with type 2 diabetes and chronic kidney disease with and without history of CVD, finerenone was associated with improved CV and kidney outcomes.
New Diabetes Device Comparison Platform Supports Clinical Decision-making, Prescribing
DiabetesWise Pro, created at Stanford University, provides an unbranded, unbiased guide to matching diabetes technology to patient needs, access, and lifestyle.
Rimegepant for Acute Migraine May Reduce Use of, Reliance on Opioids: New Data
Opioid refills were reduced by ~40% in the 9 months following an initial prescription for rimegepant among patients with migraine, a new study found.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 7, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Diabetes Technology Myths & Facts for Primary Care Practitioners
Initiating diabetes technology of any kind is a big step for patients, but also for a lot of primary care clinicians. If you have concerns, these myths and facts are for you.
ACC, AHA, HFSA 2022 Heart Failure Management Guidelines: A Guideline Topline
The new HF guidelines prioritize primary prevention, revise disease stages to encourage early intervention, and now include SGLT2i as guideline-directed medical therapy.
Patient Education via Mobile Apps: 5 Clinical Considerations
To recommend, or not recommend: that is the question clinicians may ponder when considering education-focused apps for patients. Here, 5 points to help decide.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 5, 2022
Sotagliflozin Reduced MACE Risk in Patients With and Without Prior CVD, in New Analysis of SCORED Clinical Trial
ACC 2022: Updated findings further highlight benefit of sotagliflozin treatment in patients with T2D and CKD, regardless of cardiovascular disease presence.
FDA Grants Priority Review to Dupilumab sBLA for Eosinophilic Esophagitis
Dupilumab is the only biologic to show positive, clinically meaningful phase 3 results in adults and adolescents 12 years and older with EoE.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 4, 2022
PROMPT-HF: Prescription of GDMT in Heart Failure Improves with EHR-integrated Custom Alert
ACC 2022. An EHR alert tailored to prompt clinicians to check guideline-directed medical therapy for individual HF patients was integrated carefully into clinical workflow.
Reduced Dietary Sodium in Heart Failure Patients Had Little Impact on Clinical Events: SODIUM-HF
ACC 2022. SODIUM-HF secondary findings, however, showed improvement in NYHA HF class and in QOL in the dietary intervention group.
New Study Found High Prevalence of Undiagnosed Cognitive Impairment After Myocardial Infarction
ACC 2022. Findings suggest that more attention to monitoring cognitive functioning after a myocardial infarction is needed.
Popular Hypertension-related Videos on TikTok Often Not Backed by Medical Literature, Found New Study
ACC 2022. Study assessed hypertension-related TikTok videos and found that 42% addressed alternative medicine, more than twice the number that focused on medical treatments.
Racial Minorities Less Likely to Receive CPR Regardless of Location, Community Makeup
ACC 2022. Black and Hispanic persons were 41% less likely than white individuals to receive CPR after cardiac arrest in public and 26% less likely when the event occurred in their home.
FDA Approves Higher Dose of Semaglutide (2 mg) to Reduce HbA1c in Type 2 Diabetes
The higher dose of the GLP-1 analogue allows more flexibility for patients with T2D needing to intensify treatment, says manufacturer Novo Nordisk.
Oral Gepants: Christopher Gottschalk, MD Tells the Origin Story, Highlights Broad Efficacy
The migraine-specific oral gepants are proving effective across the continuum of migraine frequency. Dr Gottschalk talks about their shaky start.
Coffee and Cardiovascular Health: Is There a Benefit?
ACC 2022. Can a couple of cups of coffee per day keep cardiovascular disease at bay? Findings from 3 new studies shed light.
Noise Pollution and MI: New Jersey Study Finds a Significant Association
ACC 2022. Approximately 5% of hospitalizations for acute MI in the state were found attributable to elevated levels of traffic noise.
